These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23449346)

  • 1. Economic and financial outcomes in transplantation: whose dime is it anyway?
    Axelrod DA
    Curr Opin Organ Transplant; 2013 Apr; 18(2):222-8. PubMed ID: 23449346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic considerations in abdominal transplantation.
    Lebovitz EE; Nguyen AVT; Sakai T
    Best Pract Res Clin Anaesthesiol; 2020 Mar; 34(1):15-23. PubMed ID: 32334783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Economics of Organ Transplantation.
    Altınörs N; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):108-111. PubMed ID: 29528004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Tremendous financial burden": Crowdfunding for organ transplantation costs in Canada.
    Pol SJ; Snyder J; Anthony SJ
    PLoS One; 2019; 14(12):e0226686. PubMed ID: 31860656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of addressing the organ shortage with clinically high-risk allografts.
    Lentine KL; Schnitzler MA
    Mo Med; 2011; 108(4):275-9. PubMed ID: 21905445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of repeat medical procedures: kidney transplantation as an example.
    Hornberger JC; Best JH; Garrison LP
    Med Decis Making; 1997; 17(4):363-72. PubMed ID: 9343794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Political and economic aspects of heart transplantation].
    Carrel T; Tschanz HU; Mohacsi P
    Schweiz Med Wochenschr; 1998 Aug; 128(35):1298-304. PubMed ID: 9782550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic implications of HLA matching in cadaveric renal transplantation.
    Schnitzler MA; Hollenbeak CS; Cohen DS; Woodward RS; Lowell JA; Singer GG; Tesi RJ; Howard TK; Mohanakumar T; Brennan DC
    N Engl J Med; 1999 Nov; 341(19):1440-6. PubMed ID: 10547408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Share 35 on the cost of liver transplantation.
    Berumen J; Misel M; Vodkin I; Halldorson JB; Mekeel KL; Hemming A
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The financial burden of transplantation: a single-center survey of liver and kidney transplant recipients.
    Rodrigue JR; Reed AI; Nelson DR; Jamieson I; Kaplan B; Howard RJ
    Transplantation; 2007 Aug; 84(3):295-300. PubMed ID: 17700152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome.
    Adler JT; Yeh H; Markmann JF; Nguyen LL
    Transplantation; 2016 Mar; 100(3):670-7. PubMed ID: 26574684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of doing what is right in renal transplantation: balancing equity and utility.
    Courtney AE; Maxwell AP
    Nephron Clin Pract; 2009; 111(1):c62-7; discussion c68. PubMed ID: 19060499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ procurement expenditures and the role of financial incentives.
    Evans RW
    JAMA; 1993 Jun 23-30; 269(24):3113-8; discussion 3155-6. PubMed ID: 8505813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States.
    Smith JM; Schnitzler MA; Gustafson SK; Salkowski NJ; Snyder JJ; Kasiske BL; Israni AK
    Transplantation; 2016 Apr; 100(4):879-85. PubMed ID: 26784114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics and ethics of kidney transplantation: perspectives in 2006.
    Kim SJ; Gordon EJ; Powe NR
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):593-8. PubMed ID: 17053473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study.
    Jacobs CL; Gross CR; Messersmith EE; Hong BA; Gillespie BW; Hill-Callahan P; Taler SJ; Jowsey SG; Beebe TJ; Matas AJ; Odim J; Ibrahim HN;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2221-31. PubMed ID: 26463883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit issues in U.S. national health legislation: the case of the End-Stage Renal Disease Program.
    Kutner NG
    Soc Probl; 1982 Oct; 30(1):51-64. PubMed ID: 11653717
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation in Cost and Quality in Kidney Transplantation.
    Nassir BA; Dean CE; Li S; Salkowski N; Solid CA; Schnitzler MA; Snyder JJ; Kim SJ; Kasiske BL; Linzer M; Israni AK
    Transplantation; 2015 Oct; 99(10):2150-7. PubMed ID: 25839707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilemmas across different overseas liver transplant stages: Taiwan transplant recipient families' perspectives.
    Chen HM; Hu RH; Shih FJ; Shih FJ
    Transplant Proc; 2012 Mar; 44(2):539-43. PubMed ID: 22410065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.